Key result
Simultaneous heart-kidney transplantation linked to ~28% lower 5-year mortality vs isolated heart transplantation in dialysis recipients.
Why the study?
Does simultaneous heart-kidney transplantation improve long-term mortality in end-stage heart failure patients with concurrent kidney dysfunction compared to isolated heart transplantation?
Cohort (n=13,539)
Yes
Does simultaneous heart-kidney transplantation improve long-term mortality in end-stage heart failure patients with concurrent kidney dysfunction compared to isolated heart transplantation?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Simultaneous heart-kidney transplantation does help patients who have end-stage HF and concurrent kidney dysfunction to some extent, but this also comes at the cost of significantly increased risk for losing the implanted kidney compared to if the kidney was transplanted in isolation. This finding might bring complex dilemmas and clinical implications, as we as clinicians focus on the patients in front of us. But, it is important that we are always cognizant of the concept of the societal utility and benefit under the limited supply of valuable organs.”
“On an individual patient level, the significant survival benefit afforded by simultaneous heart-kidney transplantation to patients with end-stage HF and varying degrees of kidney disease seen in prior studies was reaffirmed. However, on a population level, this benefit came at a significant cost, with almost twice the risk of renal allograft loss in simultaneous heart-kidney recipients compared with contralateral-lateral kidney transplant recipients. The findings of this study provide further clarity as to who may benefit from simultaneous heart-kidney transplantation and reinforces the need for a safety net allowing for appropriate organ allocation to maximize survival benefits for both heart and renal transplant candidates.”
Simultaneous heart-kidney transplantation improves survival in heart failure patients with dialysis dependence or GFR ≤40 mL/min/1.73 m2 compared to heart transplant alone, despite a higher risk of kidney allograft loss.
BACKGROUND Simultaneous heart-kidney transplantation has been increasingly performed in end-stage heart failure patients with concurrent kidney dysfunction despite limited evidence supporting its indications and utility. OBJECTIVES The purpose of this study was to investigate the effects and utility of simultaneously implanted kidney allografts with various degrees of kidney dysfunction during heart transplantation. METHODS Using the United Network for Organ Sharing registry, long-term mortality was compared in recipients with kidney dysfunction who underwent heart-kidney transplantation (n = 1,124) vs isolated heart transplantation (n = 12,415) in the United States between 2005 and 2018. In heart-kidney recipients, contralateral kidney recipients were compared for allograft loss. Multivariable Cox regression was used for risk adjustment. RESULTS Long-term mortality was lower among heart-kidney recipients than among heart-alone recipients when recipients were on dialysis (26.7% vs 38.6% at 5 years; HR: 0.72; 95% CI: 0.58-0.89) or had a glomerular filtration rate (GFR) of <30 mL/min/1.73 m2 (19.3% vs 32.4%; HR: 0.62; 95% CI: 0.46-0.82) and GFR of 30 to 45 mL/min/1.73 m2 (16.2% vs 24.3%; HR: 0.68; 95% CI: 0.48-0.97) but not in GFR of 45 to 60 mL/min/1.73 m2. Interaction analysis showed that the mortality benefit of heart-kidney transplantation continued up to GFR 40 mL/min/1.73 m2. The incidence of kidney allograft loss was higher among heart-kidney recipients than among contralateral kidney recipients (14.7% vs 4.5% at 1 year; HR: 1.7; 95% CI: 1.4-2.1). CONCLUSIONS Heart-kidney transplantation relative to heart transplantation alone provided superior survival for dialysis-dependent recipients and non-dialysis-dependent recipients up to a GFR of approximately 40 mL/min/1.73 m2 but at the cost of almost twice the risk of kidney allograft loss than contralateral kidney allograft recipients.
No takes yet. Share an insight, caveat, or question.
Itagaki et al. (2023) conducted a cohort in End-stage heart failure with concurrent kidney dysfunction (n=13,539). Simultaneous heart-kidney transplantation vs. Isolated heart transplantation was evaluated on Long-term mortality (dialysis-dependent recipients at 5 years) (HR 0.72, 95% CI 0.58-0.89). Simultaneous heart-kidney transplantation was associated with lower 5-year mortality than isolated heart transplantation in dialysis-dependent recipients.
Synapse has enriched 10 related papers. Consider them for comparative context: